World Health Strategy eBook

Based on Future of Health Technology Summits with 1000+ luminaries
produced by Renata Bushko, Founder, Future of Health Technology Institute
Happier, Longer Lives ® - FHTI since 1996, more than 1000 thinkers

A picture of the pegasus award

Future Health Technology Award

Given to the ones inspiring others to make the Earth a better place for human race: reducing suffering, maximizing the potential for self-realization of the human kind and extending human potential with technology.

A picture of Dr Guillermo

The 2019 FHTI Award Recipient

Guillermo Ulises Ruiz-Esparza, MD, PhD

Dr. Guillermo Ulises Ruiz-Esparza, Medical Doctor and BioNanotechnologist, is a pioneer in the field of nanosystems and cardiovascular nanomedicine. He was the first to achieve intravascular and site-specific nanoparticle-based delivery to a failing heart, enabling the current development of new nanotechnologies for delivering genetic material and drugs for the treatment of heart failure. He has also developed pioneering nanotechnologies for spatiotemporal and sequential release of dual therapeutic agents within the same nanosystem as published in the cover of the "Advanced Functional Materials".

Massachusetts Institute of Technology (MIT) – Technology Review recognized him with the prestigious TR35 award as one of the world's top innovators under the age of 35. Guillermo has numerous publications in “Science Translational Medicine”, “Advanced Materials”, “Advanced Functional Materials”, “European Journal of Heart Failure”, “Materials Science and Engineering. He directs the Molecular NanoSystems research group at the Division of Engineering in Medicine at Brigham and Women's Hospital and Harvard Medical School.

He received his MD and PhD in Biotechnology and Nanotechnology from the Monterrey Institute of Technology and Higher Education-Houston Methodist Hospital Joint MD/PhD Program, later on he completed his Postdoctoral training in Smart Bio and Nanomaterials at Harvard University, Massachusetts Institute of Technology (MIT) and Brigham and Women's Hospital.

A picture of Dr Li

Books featuring Li's Work

Food Allergies: Traditional Chinese Medicine, Western Science, and the Search for a Cure Traditional Chinese Medicine, Western Science, and the Fight Against Allergic Disease

The 2016 FHTI Award Recipient

Dr. Xui-Min Li

Dr. Xiu-Min Li, Director, Center for Integrative Medicine for Allergies and Wellness and Professor of Pediatric Allergy and Immunology, Mount Sinai Hospital, has been named the recipient of the 2016 Future of Health Technology Award for her research and clinical work on botanical drugs for asthma, food allergies, and other diseases of the immune system, and for her vision to make them available to patients through integrative medical practice. Allergic diseases represent a growing threat to life and quality of life in developed nations and are spreading as more countries strive for Western living standards. According to American College of Allergy, Asthma and Immunology there are approximately 50 million people with allergies in US.

The research projects of Dr. Li and her collaborators have provided major insights into the immune system with the goal of creating safe botanical drugs for food allergies, eczema, allergic rhinitis and asthma and, in the future, potentially for irritable bowel disease (IBD) and weight control, without the cytotoxicity, depression, and anxiety that frequently accompany mainstream treatment.

Her work also uncovered potential early intervention for preventing food allergy and asthma altogether. Facilitated by a dual regulatory structure, which allows botanical drugs to be used as supplements even while research on investigatory drugs continues, her novel eczema, food allergy, and asthma treatments are already helping patients in her private clinical practice. One of her many patients, Christopher Burch, Founder of Burch Creative Capital calls her “the Healing Angel”. “Dr. Li helps patients who cannot be helped by other doctors” said Barbara Winston, President of Bruce Winston Gem

Corporation, familiar with Dr. Li’s excellent clinical outcomes. The clinical experience also helps inform the laboratory science. Dr. Li has the vision of a broad collaboration to manufacture research-proven and evidence-based Chinese herbal medicines, and make them widely available through a practice network of trained allopathic physicians.

Dr. Li obtained her MD degree in Henan School of Chinese Medicine and a Master’s degree in Clinical Pediatric Immunology from The Graduate School of China Academy of Chinese Medical Sciences, where she was trained in integrative Western and Traditional Chinese Medicine.

She was Visiting Scientist at Stanford before completing a postdoctoral fellowship in Clinical Immunology at the Johns Hopkins School of Medicine, Asthma and Allergy Center, and was appointed instructor. Dr. Li was recruited to the Division of Pediatric Allergy and Immunology at Mount Sinai when the division was established in 1997.

In the past 17 years, she has investigated novel therapies for asthma and food allergy combining expertise in allergy and immunology, molecular biology and Chinese herbal medicine.

She is sponsor of US-FDA approved clinical studies of investigational new botanical drugs. In addition to the clinical studies, she has established immunobiology and botanical chemistry laboratories. Her research has resulted in nearly 100 publications.

She has given 2009 Gail G. Shapiro Memorial Lecture at the American Academy of Allergy, Asthma and Immunology. Dr. Li also served as vice Chair and then Chair of the American Academy of Allergy Asthma and Immunology (AAAAI), Complementary and Alternative Medicine Practices in Allergy Committee. Dr. Li also served as Chair of the First East-West Scientific Conference on Allergy & Traditional Medicine.

Her work is featured in Henry Ehrlich’s book “Food Allergies: Traditional Chinese Medicine, Western Science, and the Search for a Cure”.